Patients who are candidates for endotracheal intubation.
Conditions
Interventions
Intervention 1: The intervention group will receive dexmedetomidine 5 mg/kg intravenously over 10 minutes in addition to the anesthetic. Intervention 2: The control group will receive normal saline 5
Sponsors
Islamic Azad University, Khorasgan branch
Eligibility
Sex/Gender
All
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Informed consent Age between 18 and 35 years old Be physically in ASA group one and two.
Exclusion criteria
Exclusion criteria: Pregnant women History of sinus disorders History of use of heart and blood pressure medications (calcium blockers, beta blockers, etc.) History of contraindications to the use of dexmedetomidine (such as atrial fibrillation, ventricular premature beats, ventricular tachycardia, bradycardia, S-T segment changes, T wave changes, liver disorders, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate. Timepoint: Before the intervention, before endotracheal intubation and 5 minutes after endotracheal intubation. Method of measurement: Using a pulse oximetry device.;Blood pressure. Timepoint: Before the intervention, before endotracheal intubation and 5 minutes after endotracheal intubation. Method of measurement: Using a pulse oximetry device.;Blood oxygen. Timepoint: Before the intervention, before endotracheal intubation and 5 minutes after endotracheal intubation. Method of measurement: Using a pulse oximetry device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNiloofar Kaviani
Islamic Azad University, Khorasgan branch
Outcome results
None listed